Date | Time | Source | Headline | Symbol | Company |
27/09/2013 | 11:01 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
27/09/2013 | 11:01 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
24/09/2013 | 22:11 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
24/09/2013 | 21:58 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
24/09/2013 | 21:33 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
23/09/2013 | 11:01 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
20/09/2013 | 22:24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
20/09/2013 | 22:12 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
19/09/2013 | 22:32 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
19/09/2013 | 22:29 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
19/09/2013 | 11:01 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
19/09/2013 | 11:01 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
18/09/2013 | 22:30 | PR Newswire (US) | Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
18/09/2013 | 11:01 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
18/09/2013 | 11:01 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
17/09/2013 | 13:30 | Marketwired | Onyx Pharmaceuticals Announces Data Presentations at 2013 European Cancer Congress | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
11/09/2013 | 22:11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
11/09/2013 | 22:01 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/09/2013 | 14:47 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/09/2013 | 13:08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
06/09/2013 | 22:23 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
06/09/2013 | 22:18 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
06/09/2013 | 00:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
03/09/2013 | 11:34 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
03/09/2013 | 11:08 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
30/08/2013 | 07:30 | PR Newswire (US) | Bayer's Stivarga® (regorafenib) Tablets Approved in Europe | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
29/08/2013 | 20:44 | PR Newswire (US) | ONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiducia... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
29/08/2013 | 00:00 | Business Wire | Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Onyx Pharmaceuticals, Inc. Over the Proposed Sa... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
29/08/2013 | 00:00 | Business Wire | Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Onyx Pharmaceuticals, Inc. Over the Proposed Sa... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
28/08/2013 | 09:30 | Zacks | Bull of the Day: Biogen Idec (BIIB) - Bull of the Day | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |